Home GlaxoSmithKline plc's (GSK) Neutral Rating Reaffirmed at BNP Paribas
 

Keywords :   


GlaxoSmithKline plc's (GSK) Neutral Rating Reaffirmed at BNP Paribas

2016-01-09 20:38:11| Biotech - Topix.net

's stock had its "neutral" rating restated by analysts at BNP Paribas in a report issued on Friday, MarketBeat Ratings reports. They presently have a GBX 1,400 target price on the stock.

Tags: rating neutral bnp reaffirmed

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
13.06Ontex Plans Restructuring in Belgium
13.06Printing United Alliance and Stahls partner for education
13.06Catapult Print extends commitment to Bellissima DMS
13.06Housing demand wanes as buyers bank on rate cut
13.06Wizz Air ranked worst airline for delays for third year
13.06Eastern North Pacific Tropical Weather Outlook
13.06Atlantic Tropical Weather Outlook
13.06Musk says Tesla investors voting yes for pay deal
More »